Navigation Links
ICAP study uses novel incentive to encourage HIV patient care and treatment
Date:7/17/2012

In a new study by ICAP at Columbia's Mailman School of Public Health, researchers are assessing a novel approach to encourage newly diagnosed HIV positive people to seek care and adhere to HIV treatment. The unique study in the HIV Prevention Trials Network (HPTN) gives people who test HIV positive a coupon for a gift card to claim after they complete clinic visits and laboratory tests. Patients who adhere to HIV treatment regularly can decrease the amount of HIV in their blood, leading to viral suppression. Study participants who achieve viral suppression also receive gift cards as a reward and motivation for a maximum of four times a year.

Dr. Wafaa El-Sadr, ICAP director, is protocol chair for the HPTN 065 or Test Link to Care Plus Treat (TLC-Plus) Study. HPTN 065 is being conducted in the Bronx and in Washington, DC and involves 37 HIV testing sites and 39 HIV care sites in the two communities. HPTN 065 aims to determine the feasibility of enhanced testing, linkage and treatment as a strategy for HIV prevention in the U.S.

Community input played an important role in the design of the study, explained Dr. El-Sadr, who is also professor of Epidemiology and Medicine at Columbia's Mailman School. "Before we introduced our financial incentive, we had to think so carefully about what can happen that's good and what can undermine what you're trying to do," she said. "And we want to use incentives that, if they are effective, will be cost-effective for health systems."

Findings of the study are featured in Science magazine's July 13 special issue, "HIV/AIDS in America," published on the eve of the International AIDS Conference (AIDS 2012) in Washington, D.C.


'/>"/>

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Ties Infant Birth Weight to Mothers Breast Cancer Risk
2. Moms Pot Use Doubles Risk of Preemie Birth: Study
3. Study shows how aging impairs immune response
4. Physical health problems substantially increase use of mental health services, study shows
5. Study: Children abused by parents face increased cancer risk
6. Weight-Loss Surgery May Not Cut Medical Costs: Study
7. Triggers study evaluates regular staff, ICU specialists
8. UCSB study reveals brain functions during visual searches
9. Japan Nuke Disaster Will Kill Up to 1,300 People Worldwide, Study Estimates
10. New Yorks Trans-Fat Ban Is Working: Study
11. Plastics Chemical in Dental Fillings Might Affect Childrens Behavior: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... 09, 2016 , ... The Pennsylvania Athletic Trainers’ Society (PATS) ... summer of 2016. The program was made possible by a Pennsylvania Department of ... Health and Human Services Administration. The broadcast, Use Your Head: Properly Managing ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... Compensation Research Institute (WCRI) officially opened registration today for its 33rd Annual ... in Boston, MA . , The theme of the conference is “Persistent Challenges ...
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... , ... December 08, 2016 , ... With the increasing ... the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about the ... the dental implant and prosthetic market in the U.S. is projected to reach $6.4 ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Bodycad announced it has been awarded ... reproducibility and speed for 3D constructs via MRI ... orthopaedic applications. These patents are critical to the ... based on each patient,s distinct anatomy. ... the world,s first suite of orthopaedic CAD/CAM software. ...
(Date:12/8/2016)... , Dec. 8, 2016  EIP Pharma, ... has obtained proof-of-mechanism for neflamapimod (previously code named ... Phase 2a clinical trials that demonstrated significant Alzheimer,s ... 302 (12-week treatment) and Study 303 (6-week treatment) ... Trials in Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: